Table 2.
Systemic immune inflammation index in patients with psoriasis.
| Systemic Immune Inflammation Index median (IQR) | P value | |
|---|---|---|
| Female 618 (513) |
Male 655 (400) |
0.855 |
| With arthritis 656 (430) |
Without arthritis 642 (419) |
0.968 |
| Psoriasis vulgaris 644 (426) |
Other types 705 (363) |
0.456 |
| Nail involvement 696 (434) |
Without nail involvement 600 (401) |
0.210 |
| Psoriasis duration (≤20 years) 643 (429) |
Psoriasis duration (>20 years) 656 (428) |
0.466 |
| Mild/ moderate psoriasis 624 (388) |
Severe psoriasis 652 (490) |
0.267 |
| Non-obese 642 (428) |
Obese 718 (619) |
0.071 |
| Previous biological treatment 658 (411) |
Biologic-naïve 642 (436) |
0.921 |
| Unremarkable medical history 645 (395) |
With a chronic disease 648 (461) |
0.763 |
| With hypertension 687 (566) |
Without hypertension 642 (411) |
0.801 |
| With hyperlipidemia 598 (388) |
Without hyperlipidemia 658 (436) |
0.113 |
| With diabetes mellitus 651 (611) |
Without diabetes mellitus 645 (403) |
0.752 |
| With hepatic steatosis 735 (461) |
Without hepatic steatosis 643 (418) |
0.706 |
| With hepatitis B virus carriage 608 (431) |
Without hepatitis B virus carriage 650 (421) |
0.915 |
| With depression 782 (239) |
Without depression 608 (418) |
0.079 |
| With coronary artery disease 692 (521) |
Without coronary artery disease 643 (416) |
0.861 |
IQR = interquartile range.
Higher SII levels were detected in male patients, patients with severe psoriasis, patients with psoriatic arthritis, nail findings and obese patients. SII may indicate the severity of psoriasis.